About this trial
This randomized clinical trial aims to evaluate and compare the analgesic efficacy of the Intertransverse Process Block (ITP) and the Erector Spinae Plane (ESP) block in patients undergoing Robotic Colorectal Surgery. The primary outcome is the Visual Analog Scale (VAS) score within the first 24 hours after surgery. Secondary outcomes include total opioid consumption, requirement for rescue analgesia, block-related and systemic side effects (hematoma, pneumothorax, local anesthetic systemic complications, vascular puncture, and infection), patient and surgeon satisfaction assessed using a Likert scale, and quality of recovery assessed using the QoR-15 questionnaire, and incedence of postoperative nausea and vomiting.
Eligibility criteria
Qualifiers
Patients aged 18-65 years
ASA physical status I-III
Scheduled for elective robotic colorectal surgery
Body mass index (BMI) between 18 and 35 kg/m²
Disqualifiers
Refusal to participate
Allergy to local anesthetics
Infection at the injection site
Coagulopathy or ongoing anticoagulant therapy
Trial design
Treatments tested in this trial
- Intertransverse Process Block (ITP)
- The Erector Spinae Plane Block (ESP)